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Background: Randomized controlled trials (RCT) in hypertension demonstrate cardiovascular (CV) benefits when systolic blood pressures (BP) are 
reduced from higher values to <160 mmHg. The value of lower targets has not been fully defined, although major guidelines recommend achieving 
systolic BPs of < 140 mmHg.
methods: Based on a pre-specified plan to explore relationships between clinical outcomes and systolic BPs, the pooled cohort of high risk 
hypertensive patients (N=10,705) of the RCT, ACCOMPLISH, were divided into 4 strata of BP: > 140; 130 - <140; 120 - <130; and 110 - <120 
mmHg. The primary endpoint was CV death or non-fatal myocardial infarction (MI) or stroke. Outcomes comparisons between the BP groups were by 
Cox regression.
results: Mean patient age was 68 and study duration was 35.7 months. The primary endpoint occurred in 171/3429 (5.0%) patients in the 10 
mmHg range <140 and 179/2354 (7.6%) patients > 140 mmHg; hazard ratio (HR) = 0.62 (95% CI: 0.50, 0.77), P = 0.0001; similarly, CV death fell 
by 36% (P = 0.0147), total MI (fatal + non-fatal) by 37% (P = 0.0028), and stroke by 47% (P = 0.0002). CV event rates in the range <130 were not 
different from <140 mmHg. However, compared with < 130, stroke in the range < 120 mmHg was lower: HR= 0.60 (0.35, 1.01), P = 0.0529; but MI 
was higher: HR= 1.52 (1.00, 2.29), P = 0.0437; as were composite coronary events (MI or hospitalized angina or sudden death): HR= 1.63 (1.18, 
2.24), P = 0.0023. The renal endpoint of a sustained >50% increase in serum creatinine was significantly lower in the <140 mmHg range than in any 
of the other higher or lower BP ranges.
conclusion: In high risk hypertensive patients, major CV events are significantly lower in the <140 and <130 mmHg ranges than >140 mmHg. 
There are stroke benefits at <120 mmHg but they are offset by increased coronary events. Renal function is best protected in the 130-139 mmHg 
range.
